Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Insmed Incorporated - Common Stock (NQ:INSM)

177.82 +0.40 (+0.23%)
Streaming Delayed Price Updated: 10:39 AM EST, Dec 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Insmed Incorporated - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
Dow Gains 50 Points; US Small Business Optimism Index Rises In May ↗
 
Via Benzinga
Topics Stocks
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Which stocks are gapping on Tuesday? ↗
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Tuesday. Let's explore the market movements and identify the stocks with significant gaps. 
Via Chartmill
News headline image
Insmed, Tesla, Casey's General Stores And Other Big Stocks Moving Higher On Tuesday ↗
 
Via Benzinga
News headline image
How Do Investors Really Feel About Insmed? ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 8, 2025 ↗
 
Via Benzinga
News headline image
Insmed Stock Soars Pre-market After Lung Disease Drug Achieves Positive Results In Mid-Stage Trial: Retail Gets More Bullish ↗
Insmed said that it will immediately engage with the U.S. Food and Drug Administration (FDA) regarding a late-stage study design following the positive results from the mid-stage trial. 
Via Stocktwits
Topics Death
News headline image
Insmed Catapults Into Breakout Territory On A 'Home Run' For Its Rival To United, Liquidia ↗
Shares look likely to break out at the open after the biotech company unveiled promising results for a pulmonary arterial hypertension treatment. 
Via Investor's Business Daily
News headline image
This Insmed Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday ↗
 
Via Benzinga
News headline image
Analyst Expectations For Insmed's Future ↗
 
Via Benzinga
News headline image
Is Insmed Gaining or Losing Market Support? ↗
 
Via Benzinga
News headline image
Here's How Much You Would Have Made Owning Insmed Stock In The Last 5 Years ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 20, 2025 ↗
 
Via Benzinga
News headline image
Here's How Much $100 Invested In Insmed 10 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today ↗
 
Via Benzinga
News headline image
In The Holiday Shortened Easter Week, These Large-Cap Stock Were Top Performers (Apr 14-Apr 18): Are These In Your Portfolio? ↗
Top performers last week: ServiceTitan, Summit Therapeutics, YPF, Eli Lilly, MicroStrategy, America Movil, Ericsson, Insmed, Diamondback, Neurocrine Biosciences. 
Via Benzinga
News headline image
Peering Into Insmed's Recent Short Interest ↗
 
Via Benzinga
News headline image
Insmed Stock: A Deep Dive Into Analyst Perspectives (5 Ratings) ↗
 
Via Benzinga
News headline image
Here's How Much You Would Have Made Owning Insmed Stock In The Last 5 Years ↗
 
Via Benzinga
News headline image
Friday's after hours session: top gainers and losers ↗
As the regular session of the US market concludes on Friday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses. 
Via Chartmill
News headline image
A technical analysis of INSMED INC (NASDAQ:INSM). ↗
INSMED INC (NASDAQ:INSM) Reveals Intriguing Technical Aspects. Indications Suggest NASDAQ:INSM Could Be on the Verge of a Breakout. Here's What You Need to Know. 
Via Chartmill
News headline image
$1000 Invested In Insmed 10 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
Expert Outlook: Insmed Through The Eyes Of 13 Analysts ↗
 
Via Benzinga
News headline image
One Vanguard Index Fund to Buy That May Beat the S&P 500 by 100% in the Next Few Years, According to a Wall Street Analyst ↗
Via The Motley Fool
Topics Stocks
News headline image
Are Small-Cap Stocks A Buy After Russell 2000 Correction? ↗
Investors are questioning the value of small-cap stocks, as reflected by Russell 2000's 15% drop. Some top stocks saw even bigger declines. 
Via Benzinga
News headline image
First Trust's New Small-Cap ETF Aims To Combine Growth With Income ↗
First Trust launches actively managed FTKI ETF, using buy-write strategy for steady income and small-cap exposure. Expense ratio is 0.85%. 
Via Benzinga
Topics ETFs
News headline image
Lung Disease-Focused Insmed 'Is An Attractive Midcap Biotech,' Analyst Says ↗
RBC Capital initiates Insmed with an Outperform rating, citing brensocatib's launch potential and Arikayce's growth. FDA decision on brensocatib due August 2025. 
Via Benzinga
News headline image
This Insmed Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.